Daily
Mail: An implantable miniature telescope has received FDA
approval for use in the US.
The device was developed by VisionCare to treat end-stage
age-related macular degenerationâmdash;when a
blind spot develops in the central vision of the eye.Implanted
in the cornea, the device expands an incoming image onto the
peripheral parts of the retina that are undamaged from AMD,
thereby reducing the blind spot's effect. So far, the device is
slated for use in people over the age of 75 and doesn't treat
AMD directly; it can only be implanted in one eye, and the
patient has to learn how to merge the two images rendered in
order to see.
The device was developed by VisionCare to treat end-stage
age-related macular degenerationâmdash;when a
blind spot develops in the central vision of the eye.Implanted
in the cornea, the device expands an incoming image onto the
peripheral parts of the retina that are undamaged from AMD,
thereby reducing the blind spot's effect. So far, the device is
slated for use in people over the age of 75 and doesn't treat
AMD directly; it can only be implanted in one eye, and the
patient has to learn how to merge the two images rendered in
order to see.
